Replimmune

Replimune and Incyte to study cancer combo therapy in CSCC patients
Clinical Trials Arena
Tue, 08/1/23 - 10:06 am
Replimmune
Incyte
clinical trials
RP1
CSCC
cutaneous squamous cell carcinoma